Illness	Number of cases
Adverse effects not elsewhere classified (T78.1)	179
Atopic dermatitis (L20.8)	65
Abnormal results of function studies - Abnormal results of pulmonary function studies (R94.2)	61
Unspecified chronic bronchitis (J42)	44
Atopic dermatitis - Atopic dermatitis unspecified (L20.9)	27
Toxic effect of contact with venomous animals (T63.4)	24
Diseases of vocal cords and larynx not elsewhere classified - Other diseases of larynx (J38.7)	15
Contact with and exposure to communicable diseases - Contact with and suspected exposure to tuberculosis (Z20.1)	14
Acute bronchitis - Acute bronchitis due to other specified organisms (J20.8)	13
Sleep disorders - Primary central sleep apnea (G47.31)	12

Top 10 treatments

Treatment	Number
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	675
Investigation of an allergy by specifically triggering an allergic reaction (1-700)	420
Patient education (9-500.1)	299
Patient education (9-500.0)	243
Measurement of the reaction of the respiratory tract to a stimulus (1-714)	150
Anaesthesia with administration of an anaesthetic into a vein (8-900)	67
Patient education (9-500.2)	63
Examination of the bronchi by taking a sample of fluid or tissue with a needle (1-843)	60
Investigation of the activity of the heart and lungs during sleep (1-791)	50
Examination of the trachea and the bronchi by endoscopy (1-620.00)	48

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1000

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	2

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
34	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
34	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
34	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)	Famulaturen: 6
Participation in multi-centre Phase I/II studies	- CRISP-Register: NIS (Nicht interventionelle Studie): - FINN-Studie: NIS - NENI: NIS - SPACE-Studie: Einarmige Phase II Studie - SAFFRON Studie: Phase III; NSCLC - TIGER Meso: NIS Register: - Klinisches Register für schweres Asthma - Mukoviszidose Register - OHONIV_OCONIV